• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. Low-Cost Exposure to U.S. Healthcare Firms

    This ETF holds a swath of large- and mid-cap U.S. healthcare companies.

  2. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

  3. 5 Wide-Moat Stocks That Were Left Behind in 2014

    It was a good year for wide-moat stocks overall, but Exxon, Amazon, and a few others lagged the market, says Morningstar markets editor Jeremy Glaser.

  4. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  5. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  6. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    These top managers continue to focus on higher-quality dividend-paying stocks in a market that has become more volatile of late.

  7. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.

  8. Sanofi Shakes Off Patent Losses

    The drugmaker faces less long-term volatility as the focus shifts to steady businesses.

  9. Quarter Ends With a Whimper for Stock Funds

    Large-cap funds fared far better than small-cap in the U.S., while emerging markets held up better among overseas offerings, says Morningstar's Russ Kinnel.

  10. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

    A group of top managers remains cautious and commits more capital to traditional defensive sectors, while taking advantage of a rising (and potentially overvalued) market to book some gains.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.